Portfolio Update

BLACKROCK SMALLER COMPANIES TRUST PLC All information is at 30 NOVEMBER 2012 and unaudited. Performance at month end is calculated on a capital only basis One Three One Three Five Month Months Year Years Years Net asset value* -0.2% 6.2% 17.8% 74.4% 48.9% Share price* 1.8% 8.1% 27.0% 89.6% 63.7% Numis ex Inv Companies + AIM* -0.1% 5.0% 13.7% 29.7% -0.4% Sources: BlackRock and Datastream At month end Net asset value Capital only (debt at par value): 622.30p Net asset value Capital only (debt at fair value): 618.13p Net asset value incl. Income (debt at par value): 628.25p** Net asset value incl. Income (debt at fair value): 624.07p** Share price: 538.50p Discount to Cum Income NAV (debt at par value): 14.3% Discount to Cum Income NAV (debt at fair value): 13.7% Net yield: 1.8% Total assets^: £331.0m Net gearing incl. Income (debt at fair value): 10.7% 2012 Total Expense Ratio ("TER")^^: 0.7% Ordinary shares in issue#: 47,879,792 *performance calculations based on a capital only NAV with debt at par, without income reinvested. Share price performance calculations exclude income reinvestment. **includes net revenue of 5.95p ^includes current year revenue ^^As reported in the Annual Financial Statements for the year ended 29 February 2012, the TER is calculated as a percentage of net assets and using operating expenses, excluding performance fees, finance costs and taxation. #excludes 2,113,731 shares held in treasury Ten Largest Sector Weightings % of total assets Support Services 9.9 Software & Computer Services 9.0 Oil & Gas Producers 6.6 General Retailers 6.5 Electronic & Electrical Equipment 6.4 Financial Services 6.4 Chemicals 5.9 Travel & Leisure 5.4 Media 5.2 Household Goods & Home Construction 5.2 ---- Total 66.5 ==== Ten Largest Equity Investments (in alphabetical order) Company Ashtead Aveva Group AZ Electronic Materials Bellway Booker Group Howden Joinery Oxford Instruments Senior Victrex Workspace Commenting on the markets, Mike Prentis, representing the Investment Manager noted: During November the Company's NAV per share fell by 0.2% whilst the benchmark index decreased by 0.1%. The FTSE 100 Index increased by 1.5%. (All performance percentages have been calculated on a capital only basis.) Sector allocation was slightly positive with our overweight position in specialitychemicals companies contributing to relative performance. Stock selection was marginally negative. No stock contributed more than 0.25% to relative performance, positively or negatively. Our largest contributor to negative stock selection in the month was from a smaller holding, Brainjuicer. Brainjuicer warned profits would be below expectations because large corporate customers had delayed spending on market research tools late in the year. Interestingly, sales of Brainjuicer's most innovative tools were up 39% in the 10 months to 31 October 2012 compared to the prior period, but other research tools revenues were down 22% over the same period. The company has net cash and a strong management team. We expect a better performance next year and therefore we are retaining our holding. We had good results, trading updates or meetings from/with various holdings during the month including Oxford Instruments, Keller, Aveva, Hyder Consulting, Big Yellow and Workspace. There were no new holdings during the month. We continued to sell a number of small holdings where we see limited near term upside. 13 December 2012 ENDS Latest information is available by typing www.blackrock.co.uk/brsc on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager's website nor the contents of any website accessible from hyperlinks on the Manager's website (or any other website) is incorporated into, or forms part of, this announcement.
UK 100

Latest directors dealings